We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
251
PEAK6 Investments
Illinois
– -$317K -1,002 Closed
WMSA
252
Weiss Multi-Strategy Advisers
New York
– -$317K -1,000 Closed
AMCA
253
Arthur M. Cohen & Associates
Illinois
– -$313K -988 Closed
US Bancorp
254
US Bancorp
Minnesota
– -$263K -830 Closed
IWC
255
Integrated Wealth Concepts
Massachusetts
– -$262K -829 Closed
CIBC Asset Management
256
CIBC Asset Management
Ontario, Canada
– -$254K -801 Closed
PFS
257
Prospera Financial Services
Texas
– -$247K -780 Closed
MYIA
258
Mount Yale Investment Advisors
Colorado
– -$235K -743 Closed
CIM
259
CIM Investment Management
Pennsylvania
– -$232K -734 Closed
MML Investors Services
260
MML Investors Services
Massachusetts
– -$224K -708 Closed
XT
261
XTX Topco
Cayman Islands
– -$222K -702 Closed
JGGDR
262
JGP Global Gestao de Recursos
Brazil
– -$222K -701 Closed
Bank of Montreal
263
Bank of Montreal
Ontario, Canada
– -$219K -691 Closed
PAS
264
Park Avenue Securities
New York
– -$203K -641 Closed
JIC
265
Johnson Investment Counsel
Ohio
– -$201K -634 Closed
EA
266
Emerald Advisers
Pennsylvania
– -$193K -610 Closed
KBC Group
267
KBC Group
Belgium
– -$192K -607 Closed
AIG
268
American International Group
New York
– -$180K -569 Closed
CI Investments Inc
269
CI Investments Inc
Ontario, Canada
– -$173K -548 Closed
Comerica Bank
270
Comerica Bank
Texas
– -$155K -488 Closed
S
271
SignatureFD
Georgia
– -$154K -487 Closed
UB
272
UMB Bank
Missouri
– -$150K -475 Closed
ETC
273
Exchange Traded Concepts
Oklahoma
– -$146K -461 Closed
Bessemer Group
274
Bessemer Group
New Jersey
– -$138K -435 Closed
VEA
275
Virtus ETF Advisers
New York
– -$134K -423 Closed
9 10
11
12 13

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.